✦ LIBER ✦

Granular parakeratosis in a patient treated with liposomal doxorubicin for ovarian carcinoma

✍ Scribed by Laure Jaconelli; Bénédicte Doebelin; Jean Kanitakis; Benoît Ben Saïd; Michel Faure; Alain Claudy

Book ID: 116583256
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 557 KB
Volume: 58
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2007.05.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Complete resolution of psoriasis in a pa

Complete resolution of psoriasis in a patient treated with stealth liposomal doxorubicin and carboplatin for ovarian cancer

✍ Carmela Pisano; Rosa Tambaro; Massimo Di Maio; Roberta Formato; Vincenzo Rosario 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 112 KB

Interstitial pneumonitis induced by pegy

Interstitial pneumonitis induced by pegylated liposomal doxorubicin in a patient with recurrent ovarian cancer

✍ Kanako Inaba, Takahide Arimoto, Mari Hoya, Kei Kawana, Shunsuke Nakagawa, Shiro 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 170 KB

CA-125 response in patients with recurre

CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan

✍ Gabrielle Gossner; Robert L. Coleman; David G. Mutch; Neil S. Horowitz; Janet S. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Three cases of hemolytic uremic syndrome

Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin

✍ Sharyn N. Lewin; David G. Mutch; Bradford P. Whitcomb; Helen Liapis; Thomas J. H 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 218 KB

BRCA Mutation Status and Determinant of

BRCA Mutation Status and Determinant of Outcome in Women with Recurrent Epithelial Ovarian Cancer Treated with Pegylated Liposomal Doxorubicin

✍ Safra, T.; Borgato, L.; Nicoletto, M. O.; Rolnitzky, L.; Pelles-Avraham, S.; Gev 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 385 KB

A high response rate to liposomal doxoru

A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer

✍ Sarah F. Adams; Evelyn B. Marsh; Wafic Elmasri; Steffanie Halberstadt; Stephanie 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 412 KB